STAT+: The biotech scorecard for the second quarter: 18 stock-moving events to watch
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the second quarter:
Biogen. Aducanumab. FDA. June 7. Nothing more needs to be said.
Continue to STAT+ to read the full story…
